Fancd2-deficient hematopoietic stem and progenitor cells depend on augmented mitochondrial translation for survival

Srinivas Chatla1, Wei Du2, Andrew F Wilson1

  • 1Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, United States of America.

Stem Cell Research
|September 1, 2019
PubMed

Insights

Fanconi anemia (FA) protein Fancd2 normally restricts mitochondrial activity. Its absence boosts mitochondrial translation and respiration, potentially causing bone marrow failure in FA patients.

Area of Science:

  • Mitochondrial biology
  • Hematopoiesis
  • DNA repair

Background:

  • Fanconi anemia (FA) is a rare genetic disorder.
  • FA proteins, including Fancd2, are crucial for DNA repair and stress response.
  • Mitochondrial dysfunction is implicated in various diseases.

Purpose of the Study:

  • To investigate the role of Fancd2 in mitochondrial function.
  • To explore the impact of Fancd2 deficiency on mitochondrial biosynthesis and translation.
  • To understand the contribution of mitochondrial alterations to FA pathogenesis.

Main Methods:

  • Gene deletion of Fancd2 in mouse hematopoietic stem and progenitor cells (HSPCs).
  • Analysis of mitochondrial number, enzyme activity, and protein synthesis.
  • Cell-free assays to assess mitochondrial translation.
  • Assessment of mitochondrial respiration and reactive oxygen species (ROS) production.

Main Results:

  • Fancd2 deletion increased mitochondrial number, enzyme activity, and protein synthesis in HSPCs.
  • Fancd2 deficiency led to increased mitochondrial respiration and ROS production.
  • Augmented mitochondrial translation was directly linked to Fancd2 deficiency.
  • Fancd2-deficient HSPCs showed sensitivity to mitochondrial translation inhibition.

Conclusions:

  • Fancd2 restricts mitochondrial activity by regulating mitochondrial translation.
  • Increased mitochondrial translation and respiration in Fancd2-deficient cells may contribute to HSC defects and bone marrow failure in FA.
  • Targeting mitochondrial translation could be a therapeutic strategy for FA.

Related Concept Videos

Analysis of Hematopoietic Stem Progenitor Cell Metabolism12:20

Analysis of Hematopoietic Stem Progenitor Cell Metabolism

Hematopoietic stem progenitor cells (HSPCs) transition from a quiescent state to a differentiation state due to their metabolic plasticity during blood formation. Here, we present an optimized method for measuring mitochondrial respiration and glycolysis of...
7.3K
Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps07:17

Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps

Xenobiotic efflux pumps are highly active in hematopoietic stem and progenitor cells (HSPCs) and cause extrusion of TMRM, a mitochondrial membrane potential fluorescent dye. Here, we present a protocol to accurately measure mitochondrial membrane potential in HSPCs by TMRM in the presence of Verapamil, an efflux pump...
8.3K
Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia09:44

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia

We describe a method for using multiparameter flow cytometry to detect mitochondrial reactive oxygen species (ROS) in murine healthy hematopoietic stem and progenitor cells (HSPCs) and leukemia cells from a mouse model of acute myeloid leukemia (AML) driven by...
7.8K
Direct Reprogramming of Hematopoietic Progenitor Cells into Neural Stem Cells03:05

Direct Reprogramming of Hematopoietic Progenitor Cells into Neural Stem Cells

This video demonstrates the direct reprogramming of genetically modified hematopoietic progenitor cells into neuronal stem cells. Transcription factors expressed by hematopoietic progenitor cells trigger a cascade of molecular events facilitating their transformation. Further specific media is used to select and grow induced neuronal stem...
479
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Novel strategies to faithfully model somatic mutations in hematopoietic stem and progenitor cells (HSPCs) are necessary to better study hematopoietic stem cell biology and hematological malignancies. Here, a protocol to model heterozygous gain-of-function mutations in HSPCs by combining the use of CRISPR/Cas9 and dual rAAV donor transduction is...
4.8K
Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

The goal of this protocol is to isolate nonhuman primate CD34+ cells from primed bone marrow, to gene-modify these cells with lentiviral vectors, and to prepare a product for infusion into the autologous host. The total protocol length is approximately 48...
8.0K